Pharma channel feed – Endpoints News

Pharma channel feed

Senate Judiciary Committee advances patent bill with new protections for pharma challenges

6 months ago

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

6 months ago

Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'

6 months ago

Lexicon ends commercial work to focus on R&D

6 months ago

With yearslong reorganization behind it, Novartis increases its sales guidance

6 months ago

Jazz wins approval for bispecific in biliary tract cancer

6 months ago

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

6 months ago

FDA vaccine chief Peter Marks pledges to stay as long as he's welcome

6 months ago

Amgen names Stanford geneticist and biotech founder to CSO post

6 months ago

NewAmsterdam aces Phase 3 trial, but investors are skeptical

6 months ago

FDA updates label of 33-year-old cancer drug with new dose and warning

6 months ago

Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor

6 months ago

Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship

6 months ago

Pfizer partners with two more Flagship biotechs on obesity, cancer

6 months ago

GSK plots regulatory filings for PBC itch after positive Phase 3 readout

6 months ago

NICE has 'done all we can' to negotiate for Enhertu coverage, reaffirms decision not to recommend

6 months ago

FDA rejects Astellas’ effort to support longer use of eye drug Izervay

6 months ago

Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds

6 months ago

BeiGene settles final suit over future Brukinsa generics

6 months ago

Lawmakers are poking holes in pharma's favorite new way to market medicines

6 months ago

Drugmakers 'not doing everything that they could' to widen global access, new report finds

6 months ago

Merck finally has subcutaneous Keytruda results, and it's going to regulators

6 months ago

Exclusive: Synapticure raises $25M for its approach to virtual neurodegenerative disease care

6 months ago

Syndax's Revuforj wins FDA approval in aggressive form of leukemia

6 months ago

First page Previous page 24 25 262728 29 30 Next page Last page